Evaluation of Contrast-Enhanced Ultrasound in Human Crohn's Disease

Trial Profile

Evaluation of Contrast-Enhanced Ultrasound in Human Crohn's Disease

Withdrawn prior to enrolment
Phase of Trial: Phase I/II

Latest Information Update: 16 Jun 2015

At a glance

  • Drugs Perflutren (Primary)
  • Indications Crohn's disease
  • Focus Diagnostic use
  • Most Recent Events

    • 12 Jun 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
    • 08 Dec 2014 Planned initiation date changed from 1 Aug 2014 to 1 Feb 2015 as reported by ClinicalTrial.gov record.
    • 05 Jun 2014 Planned initiation date changed from 1 Mar 2014 to 1 Aug 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top